Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.670
Filter
Add more filters

Complementary Medicines
Publication year range
1.
J Steroid Biochem Mol Biol ; 215: 106022, 2022 01.
Article in English | MEDLINE | ID: mdl-34774723

ABSTRACT

Vitamin D3 (VD3) deficiency has been associated with increased risk for cirrhosis and hepatocellular carcinoma, a highly incident malignant neoplasia worldwide. On the other hand, VD3 supplementation has shown some beneficial effects in clinical studies and rodent models of chronic liver disease. However, preventive effects of dietary VD3 supplementation in cirrhosis-associated hepatocarcinogenesis is still unknow. To investigate this purpose, male Wistar rats submitted to a combined diethylnitrosamine- and thioacetamide-induced model were concomitantly supplemented with VD3 (5,000 and 10,000 IU/kg diet) for 25 weeks. Liver samples were collected for histological, biochemical and molecular analysis. Serum samples were used to measure 25-hydroxyvitamin D [25(OH)D] and alanine aminotransferase levels. Both VD3 interventions decreased hepatic collagen deposition and pro-inflammatory p65 protein levels, while increased hepatic antioxidant catalase and glutathione peroxidase activities and serum 25(OH)D, without a clear dose-response effect. Nonetheless, only the highest concentration of VD3 increased hepatic protein levels of VD receptor, while decreased the number of large preneoplastic glutathione-S-transferase- (>0.5 mm²) and keratin 8/18-positive lesions, as well the multiplicity of hepatocellular adenomas. Moreover, this intervention increased hepatic antioxidant Nrf2 protein levels and glutathione-S-transferase activity. In summary, dietary VD3 supplementation - in special the highest intervention - showed antifibrotic and antineoplastic properties in chemically-induced cirrhosis-associated hepatocarcinogenesis. The positive modulation of Nrf2 antioxidant axis may be mechanistically involved with these beneficial effects, and may guide future clinical studies.


Subject(s)
Adenoma, Liver Cell/prevention & control , Carcinoma, Hepatocellular/prevention & control , Dietary Supplements , Liver Cirrhosis/drug therapy , Liver Neoplasms/prevention & control , Vitamin D/administration & dosage , Adenoma, Liver Cell/chemically induced , Adenoma, Liver Cell/metabolism , Adenoma, Liver Cell/pathology , Alanine Transaminase/blood , Alanine Transaminase/genetics , Animals , Carcinoma, Hepatocellular/chemically induced , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Catalase/blood , Catalase/genetics , Chemoprevention/methods , Collagen/genetics , Collagen/metabolism , Diethylnitrosamine/toxicity , Gene Expression Regulation/drug effects , Glutathione Peroxidase/blood , Glutathione Peroxidase/genetics , Glutathione Transferase/genetics , Glutathione Transferase/metabolism , Keratins/genetics , Keratins/metabolism , Liver/drug effects , Liver/metabolism , Liver/pathology , Liver Cirrhosis/chemically induced , Liver Cirrhosis/metabolism , Liver Cirrhosis/pathology , Liver Neoplasms/chemically induced , Liver Neoplasms/metabolism , Liver Neoplasms/pathology , Male , NF-E2-Related Factor 2/genetics , NF-E2-Related Factor 2/metabolism , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Nucleocytoplasmic Transport Proteins/genetics , Nucleocytoplasmic Transport Proteins/metabolism , Rats , Rats, Wistar , Receptors, Calcitriol/genetics , Receptors, Calcitriol/metabolism , Thioacetamide/toxicity , Vitamin D/analogs & derivatives , Vitamin D/blood
2.
Int J Mol Sci ; 22(23)2021 Dec 03.
Article in English | MEDLINE | ID: mdl-34884891

ABSTRACT

The essential trace element selenium (Se) is needed for the biosynthesis of selenocysteine-containing selenoproteins, including the secreted enzyme glutathione peroxidase 3 (GPX3) and the Se-transporter selenoprotein P (SELENOP). Both are found in blood and thyroid colloid, where they serve protective functions. Serum SELENOP derives mainly from hepatocytes, whereas the kidney contributes most serum GPX3. Studies using transgenic mice indicated that renal GPX3 biosynthesis depends on Se supply by hepatic SELENOP, which is produced in protein variants with varying Se contents. Low Se status is an established risk factor for autoimmune thyroid disease, and thyroid autoimmunity generates novel autoantigens. We hypothesized that natural autoantibodies to SELENOP are prevalent in thyroid patients, impair Se transport, and negatively affect GPX3 biosynthesis. Using a newly established quantitative immunoassay, SELENOP autoantibodies were particularly prevalent in Hashimoto's thyroiditis as compared with healthy control subjects (6.6% versus 0.3%). Serum samples rich in SELENOP autoantibodies displayed relatively high total Se and SELENOP concentrations in comparison with autoantibody-negative samples ([Se]; 85.3 vs. 77.1 µg/L, p = 0.0178, and [SELENOP]; 5.1 vs. 3.5 mg/L, p = 0.001), while GPX3 activity was low and correlated inversely to SELENOP autoantibody concentrations. In renal cells in culture, antibodies to SELENOP inhibited Se uptake. Our results indicate an impairment of SELENOP-dependent Se transport by natural SELENOP autoantibodies, suggesting that the characterization of health risk from Se deficiency may need to include autoimmunity to SELENOP as additional biomarker of Se status.


Subject(s)
Autoantibodies/blood , Hashimoto Disease/immunology , Selenium/blood , Selenoprotein P/immunology , Adult , Animals , Autoimmunity , Female , Glutathione Peroxidase/blood , Glutathione Peroxidase/metabolism , Hashimoto Disease/blood , Hashimoto Disease/metabolism , Humans , Male , Middle Aged
3.
Acta Vet Hung ; 69(3): 256-265, 2021 09 07.
Article in English | MEDLINE | ID: mdl-34491901

ABSTRACT

A severe form of recurrent exertional rhabdomyolysis occurs enzootically in a well-defined region of Transylvania, Harghita county. At the highest lying two settlements (more than 800 m above sea level), the prevalence of equine rhabdomyolysis is between 17 and 23%, while in the neighbouring villages in the valley it is less than 2%. The objective of our study was to clarify the role of selenium and vitamin E in the high prevalence of rhabdomyolysis in that region. Soil and hay samples were collected from each area to evaluate mineral content. Ten horses from the non-affected and 20 horses from the affected area were tested for serum selenium, vitamin E, glutathione peroxidase (GSH-Px), muscle enzymes, lactate and electrolytes. Hay samples collected from the affected area had lower selenium content. Horses in the affected regions had significantly lower serum selenium (P = 0.006) and GSH-Px levels than animals living in the non-affected regions. A good correlation between erythrocyte GSH-Px and serum selenium concentration could be demonstrated (r = 0.777, P < 0.001). Serum vitamin E levels were low independently of the origin of the horse. Based on our results, selenium deficiency possibly has a role in the Transylvanian enzootic equine recurrent rhabdomyolysis syndrome.


Subject(s)
Horse Diseases , Rhabdomyolysis , Selenium , Vitamin E , Animals , Glutathione Peroxidase/blood , Horse Diseases/epidemiology , Horses , Rhabdomyolysis/epidemiology , Rhabdomyolysis/veterinary , Romania/epidemiology , Selenium/blood , Vitamin E/blood
4.
Toxicol Ind Health ; 37(5): 251-259, 2021 May.
Article in English | MEDLINE | ID: mdl-34078187

ABSTRACT

This study investigated hepatic oxidative damage in rats following long-term manganese (Mn) exposure and clarified the underlying mechanisms. Forty-eight rats (SPF, male) were randomly assigned to receive low (10 mg/kg, n = 16) or high doses of Mn (50 mg/kg, n = 16) or sterilized distilled water (control group, n = 16). Rats were euthanized after 12 months, and liver Mn levels and histopathological changes were determined. Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels and liver malondialdehyde (MDA), glutathione peroxidase (GSH-PX), nuclear factor E2-related factor-2 (Nrf2), heme oxygenase-1 (HO-1), and NAD(P)H quinine oxidoreductase-1 (NQO1) levels were also determined. The Mn concentration and relative liver weights were significantly higher in the high-dose Mn group than in the control and low-dose Mn exposure groups. Low-dose Mn exposure resulted in mild expansion of hepatic sinuses and intact nuclei, whereas high-dose exposure led to pathological alterations in hepatocytes. High-dose Mn treatment significantly increased AST, ALT, and MDA activities and decreased GSH-PX activity. Additionally, liver Nrf2, HO-1, and NQO1 protein expression were markedly reduced by Mn exposure. Under the study conditions, long-term low-dose Mn exposure resulted in slight pathological changes in liver structure, but high-dose Mn exposure affected both liver structure and function, which might be related to the inhibition of Nrf2 expression, suppression of the transcription of its underlying antioxidant genes, and down regulation of the corresponding proteins. Consequently, the antioxidant capacity in the rat liver was weakened.


Subject(s)
Chemical and Drug Induced Liver Injury/etiology , Chemical and Drug Induced Liver Injury/genetics , Chemical and Drug Induced Liver Injury/physiopathology , Manganese/blood , Manganese/toxicity , NF-E2-Related Factor 2/drug effects , Oxidative Stress/drug effects , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Dose-Response Relationship, Drug , Glutathione Peroxidase/blood , Heme Oxygenase-1/blood , Male , Malondialdehyde/blood , NAD(P)H Dehydrogenase (Quinone)/blood , Rats , Rats, Sprague-Dawley
5.
BMC Nephrol ; 22(1): 162, 2021 05 02.
Article in English | MEDLINE | ID: mdl-33933022

ABSTRACT

BACKGROUND: Monosodium glutamate (MSG) is frequently consumed as a flavor enhancer or food additive. Possible damages induced by MSG effects on some organs have been stated in experimental animal models. The aim of the present study was to evaluate the protective effects of L-carnitine (L-ca) on the renal tissue in MSG-Induced Rats. METHODS: In this regard, 60 male rats were randomly divided into six groups (n = 10/each): 1 (Control); 2 (sham); 3 (L-carnitine 200 mg/kg b.w); 4 (MSG 3 g/kg b.w); 5 (MSG + L-carnitine 100 mg/kg); and 6 (MSG + L-carnitine 200 mg/kg). After 6 months, the rats were sacrificed, the blood sample collected and the kidneys harvested for evaluation of biochemical analytes, genes expression, and histopathological changes. RESULTS: MSG significantly increased the serum level of MDA, BUN, creatinine, uric acid and renal Caspase-9, NGAL and KIM-1 expression, but it decreased the serum activity also renal expression of SOD, catalase, GPX, and Bcl-2 expression compared to the control group. Treatment with L-ca significantly reduced the serum BUN, creatinine, uric acid and MDA level and increased catalase, GPX and SOD compared to the MSG group. However, only administration of L-ca 200 significantly decreased the caspase-9, NGAL and KIM-1; also, it increased the Bcl-2 expression in the kidney compared to the MSG group. CONCLUSIONS: Our findings indicated that L-carnitine had a major impact on the cell protection and might be an effective therapy in ameliorating the complications of the kidney induced by MSG via its antioxidant and anti-apoptotic properties.


Subject(s)
Antioxidants/pharmacology , Carnitine/pharmacology , Caspase 9/drug effects , Kidney/drug effects , Proto-Oncogene Proteins c-bcl-2/drug effects , Sodium Glutamate/toxicity , Animals , Apoptosis/drug effects , Calcium/blood , Caspase 9/genetics , Catalase/blood , Gene Expression/drug effects , Glutathione Peroxidase/blood , Humans , Kidney/enzymology , Kidney/pathology , Male , Malondialdehyde/blood , Phosphorus/blood , Proto-Oncogene Proteins c-bcl-2/genetics , Random Allocation , Rats, Sprague-Dawley , Superoxide Dismutase/blood
6.
Molecules ; 26(7)2021 Apr 04.
Article in English | MEDLINE | ID: mdl-33916540

ABSTRACT

Metabolic syndrome (MS) is the association of three or more pathologies among which obesity, hypertension, insulin resistance, dyslipidemia, and diabetes are included. It causes oxidative stress (OS) and renal dysfunction. Hibiscus sabdariffa L. (HSL) is a source of natural antioxidants that may control the renal damage caused by the MS. The objective of this work was to evaluate the effect of a 2% HSL infusion on renal function in a MS rat model induced by the administration of 30% sucrose in drinking water. 24 male Wistar rats were divided into 3 groups: Control rats, MS rats and MS + HSL rats. MS rats had increased body weight, systolic blood pressure, triglycerides, insulin, HOMA index, and leptin (p ≤ 0.04). Renal function was impaired by an increase in perfusion pressure in the isolated and perfused kidney, albuminuria (p ≤ 0.03), and by a decrease in clearance of creatinine (p ≤ 0.04). The activity of some antioxidant enzymes including the superoxide dismutase isoforms, peroxidases, glutathione peroxidase, glutathione-S-transferase was decreased (p ≤ 0.05). Lipoperoxidation and carbonylation were increased (p ≤ 0.001). The nitrates/nitrites ratio, total antioxidant capacity, glutathione levels and vitamin C were decreased (p ≤ 0.03). The treatment with 2% HSL reversed these alterations. The results suggest that the treatment with 2% HSL infusion protects renal function through its natural antioxidants which favor an improved renal vascular response. The infusion contributes to the increase in the glomerular filtration rate, by promoting an increase in the enzymatic and non-enzymatic antioxidant systems leading to a decrease in OS and reestablishing the normal renal function.


Subject(s)
Albuminuria/drug therapy , Anti-Obesity Agents/pharmacology , Antioxidants/pharmacology , Hibiscus/chemistry , Hypolipidemic Agents/pharmacology , Kidney/drug effects , Metabolic Syndrome/drug therapy , Albuminuria/blood , Albuminuria/pathology , Animals , Anti-Obesity Agents/isolation & purification , Antioxidants/isolation & purification , Ascorbic Acid/blood , Blood Pressure/drug effects , Body Weight/drug effects , Creatinine/blood , Glomerular Filtration Rate/drug effects , Glutathione/blood , Glutathione Peroxidase/blood , Glutathione Transferase/blood , Hypolipidemic Agents/isolation & purification , Insulin/blood , Kidney/metabolism , Kidney/physiopathology , Leptin/blood , Male , Metabolic Syndrome/blood , Metabolic Syndrome/pathology , Plant Extracts/chemistry , Rats , Rats, Wistar , Superoxide Dismutase/blood , Triglycerides/blood
7.
Nutrients ; 13(2)2021 Feb 14.
Article in English | MEDLINE | ID: mdl-33672988

ABSTRACT

The trace element selenium (Se) is taken up from the diet and is metabolized mainly by hepatocytes. Selenoprotein P (SELENOP) constitutes the liver-derived Se transporter. Biosynthesis of extracellular glutathione peroxidase (GPx3) in kidney depends on SELENOP-mediated Se supply. We hypothesized that peri-operative Se status may serve as a useful prognostic marker for the outcome in patients undergoing liver transplantation due to hepatocellular carcinoma. Serum samples from liver cancer patients were routinely collected before and after transplantation. Concentrations of serum SELENOP and total Se as well as GPx3 activity were determined by standardized tests and related to survival, etiology of cirrhosis/carcinoma, preoperative neutrophiles, lymphocytes, thyrotropin (TSH) and Child-Pugh and Model for End-Stage Liver Disease (MELD) scores. A total of 221 serum samples from 79 transplanted patients were available for analysis. The Se and SELENOP concentrations were on average below the reference ranges of healthy subjects. Patients with ethanol toxicity-dependent etiology showed particularly low SELENOP and Se concentrations and GPx3 activity. Longitudinal analysis indicated declining Se concentrations in non-survivors. We conclude that severe liver disease necessitating organ replacement is characterized by a pronounced Se deficit before, during and after transplantation. A recovering Se status after surgery is associated with positive prognosis, and an adjuvant Se supplementation may, thus, support convalescence.


Subject(s)
Carcinoma, Hepatocellular/blood , Liver Neoplasms/blood , Liver Transplantation/mortality , Selenium/blood , Trace Elements/blood , Adult , Aged , Biomarkers/blood , Carcinoma, Hepatocellular/mortality , Carcinoma, Hepatocellular/surgery , Female , Glutathione Peroxidase/blood , Humans , Liver Neoplasms/mortality , Liver Neoplasms/surgery , Longitudinal Studies , Male , Middle Aged , Nutritional Status , Postoperative Period , Preoperative Period , Prognosis , Selenoprotein P/blood , Severity of Illness Index , Survival Analysis , Treatment Outcome
8.
J Ethnopharmacol ; 270: 113792, 2021 Apr 24.
Article in English | MEDLINE | ID: mdl-33422656

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Cisplatin (CP), one of the most commonly used antitumor drugs in clinic, could induce reproductive and genetic toxicity. Traditional Chinese medicine believed that this side effect might be caused by the deficiency of both qi and blood. Panax notoginseng (Burk.) F. H. Chen (PN) is a traditional precious Chinese medicine for nourishing blood and hemostasis, which had the synergistic antitumor and reducing toxicity effects. However, the protective effect and mechanism of PN on CP-induced reproductive and genetic toxicity were still unknown. AIM OF THE STUDY: This study was designed to illuminate the possible protective effect and mechanism of PN on CP-induced reproductive and genetic toxicity. MATERIALS AND METHODS: Network pharmacology was first applied to analyze the potential components and targets of PN against CP-induced reproductive and genetic toxicity. Then, the results of network pharmacology were validated in a mouse model of reproductive and genotoxicity induced by CP. Body weight, testis weight, epididymis weight, sperm count, sperm viability and sperm morphology were used to assess protective effects of PN on CP-induced reproductive toxicity. Tail moment in peripheral blood cells and micronucleus in bone marrow cells were used to assess protective effects of PN on CP-induced genetic toxicity. Finally, possible protective targets obtained from network pharmacology, including 8-hydroxy-2-deoxyguanosine (8-OHdG), malondialdehyde (MDA), total superoxide dismutase (T-SOD) and glutathione peroxidase (GSH-Px), were experimentally validated by ELISA. RESULTS: One hundred and nineteen components of PN and sixty-eight targets of reproductive/genetic toxicity were acquired and constituted as the component-target network. Network pharmacology analysis showed alleviating oxidative stress might play important role in therapeutic mechanism of PN. In verified experiments, PN significantly improved the decline of body weight, testis weight and epididymis weight, increased sperm count and viability, decreased abnormal sperm morphology rate induced by CP in mice. Moreover, PN also significantly decreased the tail moment in peripheral blood cells and micronucleus formation rate in bone marrow cells in CP-induced mice. Finally, not only the decrease of T-SOD and GSH-Px level but also the increase of 8-OHdG and MDA level in serum were restored under PN treatment. CONCLUSION: Current study found that PN could improve CP-induced reproductive and genetic toxicity, which were probably attributed to alleviating oxidative stress. This finding provided the new perspective for understanding the therapeutic effect of PN on CP-induced reproductive and genetic toxicity and facilitating the clinical use of PN.


Subject(s)
DNA Damage/drug effects , Drug-Related Side Effects and Adverse Reactions/drug therapy , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/pharmacology , Panax notoginseng/chemistry , Reproduction/drug effects , 8-Hydroxy-2'-Deoxyguanosine/blood , Animals , Blood Cells/drug effects , Body Weight/drug effects , Bone Marrow Cells/drug effects , Cisplatin/toxicity , Disease Models, Animal , Drugs, Chinese Herbal/therapeutic use , Epididymis/drug effects , Glutathione Peroxidase/blood , Male , Malondialdehyde/blood , Mice , Oxidative Stress/drug effects , Protein Interaction Maps , Spermatozoa/drug effects , Spermatozoa/pathology , Superoxide Dismutase/blood , Testis/drug effects
9.
J Hum Nutr Diet ; 34(1): 64-72, 2021 02.
Article in English | MEDLINE | ID: mdl-32683790

ABSTRACT

BACKGROUND: The pathogenesis of diabetes is accompanied by oxidative stress. Citrulline can be considered as a potent antioxidant. The present study aimed to examine the effects of citrulline supplementation on the status of oxidative stress and serum levels of nitrite/nitrate (NOx) in patients suffering from type 2 diabetes (T2DM). METHODS: The present study comprises a double-blind placebo-controlled randomised clinical trial. The study subjects include 54 patients with T2DM chosen from specialised clinics of Tabriz University of Medical Sciences. The patients were allocated to one of the placebo or intervention groups. The patients in the placebo and the intervention group received one sachet of microcrystalline cellulose or l-citrulline (3 g), respectively, every day for 2 months. Malondialdehyde (MDA), glutathione peroxidase (GPx), total antioxidant capacity (TAC), superoxide dismutase (SOD), serum levels of fasting blood sugar (FBS), citrulline and NOx were assessed before and after the intervention. RESULTS: Forty-five patients completed the trial. Significant decreases were found in serum levels of FBS and MDA. Serum levels of TAC, citrulline and NOx in the intervention group increased compared to those of the placebo group, after adjusting the data for the baseline values and confounders. Differences between and within the two groups were statistically nonsignificant for GPx and SOD at the end of the study. Body mass index and energy intake were not changed significantly after the intervention. CONCLUSIONS: The results of the present study show the positive effects of citrulline supplementation with respect to attenuating FBS levels and oxidative stress, as well as boosting NOx status, in patients with T2DM.


Subject(s)
Antioxidants/pharmacology , Blood Glucose/drug effects , Citrulline/pharmacology , Diabetes Mellitus, Type 2/drug therapy , Nitrates/blood , Nitrites/blood , Oxidative Stress/drug effects , Adult , Dietary Supplements , Double-Blind Method , Female , Glutathione Peroxidase/blood , Humans , Iran/epidemiology , Male , Malondialdehyde/blood , Middle Aged , Superoxide Dismutase/blood
10.
Food Chem ; 344: 128688, 2021 May 15.
Article in English | MEDLINE | ID: mdl-33246686

ABSTRACT

Tibial dyschondroplasia (TD) is the common leg disease in commercial broilers. However, the effects of TD on meat quality and the protective of Morinda officinalis polysaccharide (MOP) are largely unknown. Three hundred broiler chicks (one-day-old) were equally allocated into control (CON), TD and MOP-treated groups for 15 days. The results indicated that TD influenced morphology and meat quality-related parameters of the breast muscle, and changed the activity and mRNA expression of antioxidant enzymes in plasma and breast muscles. Moreover, metabolomics profiling of breast muscle revealed that the main altered metabolites 4-guanidinobutyric acid and chenodeoxycholic acid, which are related to meat quality and oxidative stress. Additionally, 500 mg/L MOP effectively restored the content of meat metabolites and oxidative damage. These findings suggest that oxidative damage caused by TD may affect meat quality in broilers by changing the content of breast muscle metabolites and that MOP supplementation has a restorative effect.


Subject(s)
Meat/analysis , Morinda/metabolism , Osteochondrodysplasias/pathology , Oxidative Stress/drug effects , Polysaccharides/pharmacology , Poultry Diseases/pathology , Animals , Chickens/metabolism , Diet/veterinary , Discriminant Analysis , Glutathione Peroxidase/blood , Glutathione Peroxidase/genetics , Glutathione Peroxidase/metabolism , Hydrogen-Ion Concentration , Least-Squares Analysis , Malondialdehyde/blood , Malondialdehyde/metabolism , Osteochondrodysplasias/metabolism , Pectoralis Muscles/drug effects , Pectoralis Muscles/enzymology , Pectoralis Muscles/metabolism , Polysaccharides/chemistry , Poultry Diseases/metabolism , Superoxide Dismutase/blood , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism
11.
J Sci Food Agric ; 101(6): 2592-2600, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33063320

ABSTRACT

BACKGROUND: 25-Hydroxycholecalciferol (25OHD3 ) is a new feed additive, which is a potential alternative to vitamin D3 in swine nutrition. The objective of this study was to determine the effects of different doses of 25OHD3 supplementation on performance, immunity, antioxidant capacity, intestinal morphology and bone quality in piglets. RESULTS: As dietary 25OHD3 supplementation increased, the average daily gain (ADG) improved (P < 0.05) quadratically during days 1-14, and tended to increase (P = 0.06) quadratically during the overall period of the experiment. Increasing 25OHD3 supplementation increased (linear effect, P < 0.05) the serum 25OHD3 level and serum glutathione peroxidase (GSH-Px) activity. On day 14, serum immunoglobulin A (IgA) was increased (linear and quadratic effects, P < 0.05) as dietary 25OHD3 supplementation increased. On day 28, serum IgA level was higher (P < 0.05) linearly and the complement 3 (C3) level was reduced (P < 0.05) linearly as dietary supplementation of 25OHD3 increased. The mucosal GSH-Px activity of the small intestine was higher (quadratic effect, P < 0.05) with increasing 25OHD3 supplementation. Jejunal villus height (P = 0.06) and villus height to crypt depth ratio (P = 0.07) tended to increase quadratically, and the villus height to crypt-depth ratio of the ileum increased (P < 0.05) linearly and quadratically with increasing 25OHD3 supplementation. Dietary supplementation with an increasing level of 25OHD3 increased breaking strength of tibias and femurs (quadratic effect, P < 0.05). CONCLUSION: Increasing dietary 25OHD3 supplementation partly improved performance, immunity, antioxidant status, intestinal morphology, and bone properties of weaned piglets. © 2020 Society of Chemical Industry.


Subject(s)
Antioxidants/metabolism , Bone and Bones/drug effects , Calcifediol/administration & dosage , Dietary Supplements/analysis , Intestine, Small/growth & development , Swine/immunology , Animals , Bone and Bones/chemistry , Bone and Bones/metabolism , Female , Glutathione Peroxidase/blood , Immunoglobulin A/blood , Intestinal Mucosa/growth & development , Intestinal Mucosa/metabolism , Intestine, Small/anatomy & histology , Intestine, Small/drug effects , Intestine, Small/metabolism , Male , Swine/blood , Swine/growth & development , Weaning
12.
J Complement Integr Med ; 17(3)2020 Sep 23.
Article in English | MEDLINE | ID: mdl-33001852

ABSTRACT

Background Adiantum lunulatum Burm. F. leaf (AL) and its related species have been used traditionally for the treatment of various diseases. Objective The present study evaluated the hepatoprotective, and antioxidant activities of ethanolic extract of AL. Methodology and Result The hepatoprotective effect of AL was evaluated against ethanol-induced hepatotoxicity in rats. Administration of ethanol (2 g/kg) showed a significant biochemical and histological deterioration in the liver of experimental animals. Pretreatment with ethanolic extract of AL (250 and 500 mg/kg b.wt. p.o) significantly reduced the elevated levels of serum enzymes like serum glutamic-oxaloacetic transaminase (AST), serum glutamic-pyruvic transaminase (ALT), alkaline phosphatase (ALP), total protein, total bilirubin and reversed the hepatic damage in the liver which evidenced the hepatoprotective activity. The superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) level notably increased due to doses of AL. Conclusion The results of the present study demonstrate that the ethanolic extract of AL possesses hepatoprotective and antioxidant activities. Graphical Abstract.


Subject(s)
Adiantum/chemistry , Antioxidants/pharmacology , Chemical and Drug Induced Liver Injury/drug therapy , Plant Extracts/pharmacology , Plant Leaves/chemistry , Protective Agents/pharmacology , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Catalase/blood , Chemical and Drug Induced Liver Injury/blood , Ethanol , Glutathione/blood , Glutathione Peroxidase/blood , Liver/drug effects , Male , Phytotherapy , Rats , Rats, Sprague-Dawley , Superoxide Dismutase/blood
13.
Pol J Vet Sci ; 23(3): 341-347, 2020 Sep.
Article in English | MEDLINE | ID: mdl-33006848

ABSTRACT

This study was conducted to determine the serum and milk levels of thiobarbturic acid-reac- tive substances (TBARS), nitric oxide (NO), superoxide dismutase (SOD), glutathione peroxi- dase (GSH-Px), vitamin E and selenium, IL-4 and IL-6 in lactating dairy cows affected with bloody milk using commercially available ELISA kits. Milk and whole blood samples were collected from 60 cows affected with bloody milk and 20 apparently healthy cows for control. In the serum, levels of GSH-Px and SOD were significantly (p˂0.05) higher in healthy cows compared to cows affected with bloody milk while the levels of TBARS and NO were significantly (p˂0.05) higher in affected cows. In the milk, levels of SOD, TBARS and NO were significantly (p˂0.05) higher in affected cows. In the serum, levels of vitamin E were significantly (p˂0.05) lower in affected cows compared to healthy cows, while no significant changes were observed in the levels of this vitamin in the milk between healthy and affected cows. In the serum, levels of selenium were significantly (p˂0.05) lower in affected cows while in milk, selenium levels were significantly (p˂0.05) higher in affected cows compared to healthy ones. Levels of IL-4 were significantly (p˂0.05) lower in the serum and milk of affected cows compared to healthy cows while levels of IL-6 were significantly (p˂0.05) higher in both serum and milk of affected cows. Results of this study suggest a possible role of oxidative stress in the pathogenesis of bloody milk in dairy cows.


Subject(s)
Antioxidants/metabolism , Milk/chemistry , Oxidants/blood , Animals , Antioxidants/chemistry , Biomarkers , Cattle , Female , Glutathione Peroxidase/blood , Glutathione Peroxidase/chemistry , Interleukin-4/blood , Interleukin-4/chemistry , Interleukin-6/blood , Interleukin-6/chemistry , Nitric Oxide/blood , Nitric Oxide/chemistry , Oxidants/chemistry , Selenium/blood , Selenium/chemistry , Superoxide Dismutase/blood , Superoxide Dismutase/chemistry , Thiobarbituric Acid Reactive Substances/chemistry , Thiobarbituric Acid Reactive Substances/metabolism , Vitamin E/blood , Vitamin E/chemistry
14.
Food Funct ; 11(10): 8659-8669, 2020 Oct 21.
Article in English | MEDLINE | ID: mdl-32936195

ABSTRACT

We aimed to evaluate the anti-fatigue effects of the oyster polypeptide (OP) fraction and its regulatory effect on the gut microbiota in mice. Our exhaustive swimming experiment showed that the swimming time of the low-, middle- and high-dose groups of the OP fraction was increased by 1.82, 2.18 and 2.44 times compared with the control group, respectively. Besides, the liver glycogen levels of the three groups were increased by 19.3%, 42.02% and 65.07%, while the lactate levels were decreased by 18.85%, 21.18% and 28.74%, respectively. Moreover, administration of the OP fraction upregulated the expressions of PEPCK and AMPK, but downregulated the TNF-α expression. Correlation analysis between the gut microbiota and fatigue-related biochemical indicators showed that Faecalibacterium, Desulfovibri and Intestinibacter were negatively correlated with the swimming time, blood lactate, blood urea nitrogen, liver glycogen and muscle glycogen, while Yaniella and Romboutsia were positively correlated. Therefore, the OP fraction had anti-fatigue effects, and could regulate the abundance of gut microbiota and maintain its balance.


Subject(s)
Fatigue , Gastrointestinal Microbiome/drug effects , Ostreidae/chemistry , Peptides/pharmacology , Animals , Blood Urea Nitrogen , Body Weight/drug effects , Fatigue/genetics , Fatigue/metabolism , Fatigue/microbiology , Fatigue/pathology , Gene Expression , Glutathione Peroxidase/blood , Glycogen/metabolism , Lactic Acid/blood , Liver/cytology , Liver/drug effects , Liver Glycogen/metabolism , Male , Mice , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Peptides/chemistry , Physical Exertion , Superoxide Dismutase/blood , Swimming
15.
Oxid Med Cell Longev ; 2020: 1813798, 2020.
Article in English | MEDLINE | ID: mdl-32908623

ABSTRACT

Hemp seed has been used as a traditional oriental medicine and health food in China for centuries. Polysaccharides from hemp seed (HSP) exhibit important properties of intestinal protection, but there are limited data on the specific underlying mechanism. The primary objective of this study was to investigate the protective effect of HSP on intestinal oxidative damage induced by cyclophosphamide (Cy) in mice. The results showed that pretreatment with HSP significantly increased the average daily gain, thymus index, spleen index, superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activity in serum and ileal homogenate and significantly reduced malondialdehyde (MDA) content in ileal homogenate. In addition, the expression levels of SOD, GSH-Px, Nrf2, heme oxidase-1 (HO-1), and quinoneoxidoreductase-1 (NQO1) mRNA in ileal homogenate were significantly increased. Western blot results showed that HSP significantly upregulated the expression of Nrf2 protein and downregulated the expression of Keap1 protein in the ileum. Collectively, our findings indicated that HSP had protective effects on intestinal oxidative damage induced by Cy in mice, and its mechanism might be related to the activation of Nrf2-Keap1 signaling pathway.


Subject(s)
Cannabis/chemistry , Cyclophosphamide/adverse effects , Kelch-Like ECH-Associated Protein 1/metabolism , NF-E2-Related Factor 2/metabolism , Oxidative Stress/drug effects , Polysaccharides/pharmacology , Seeds/chemistry , Signal Transduction , Animals , Body Weight/drug effects , Catalase/blood , Glutathione Peroxidase/blood , Ileum/metabolism , Inactivation, Metabolic/genetics , Jejunum/drug effects , Jejunum/ultrastructure , Male , Malondialdehyde/metabolism , Mice, Inbred ICR , Monosaccharides/analysis , Organ Specificity/drug effects , Protective Agents/pharmacology , Signal Transduction/drug effects , Spectroscopy, Fourier Transform Infrared , Superoxide Dismutase/blood
16.
Nutrients ; 12(7)2020 Jul 16.
Article in English | MEDLINE | ID: mdl-32708526

ABSTRACT

SARS-CoV-2 infections underlie the current coronavirus disease (COVID-19) pandemic and are causative for a high death toll particularly among elderly subjects and those with comorbidities. Selenium (Se) is an essential trace element of high importance for human health and particularly for a well-balanced immune response. The mortality risk from a severe disease like sepsis or polytrauma is inversely related to Se status. We hypothesized that this relation also applies to COVID-19. Serum samples (n = 166) from COVID-19 patients (n = 33) were collected consecutively and analyzed for total Se by X-ray fluorescence and selenoprotein P (SELENOP) by a validated ELISA. Both biomarkers showed the expected strong correlation (r = 0.7758, p < 0.001), pointing to an insufficient Se availability for optimal selenoprotein expression. In comparison with reference data from a European cross-sectional analysis (EPIC, n = 1915), the patients showed a pronounced deficit in total serum Se (mean ± SD, 50.8 ± 15.7 vs. 84.4 ± 23.4 µg/L) and SELENOP (3.0 ± 1.4 vs. 4.3 ± 1.0 mg/L) concentrations. A Se status below the 2.5th percentile of the reference population, i.e., [Se] < 45.7 µg/L and [SELENOP] < 2.56 mg/L, was present in 43.4% and 39.2% of COVID samples, respectively. The Se status was significantly higher in samples from surviving COVID patients as compared with non-survivors (Se; 53.3 ± 16.2 vs. 40.8 ± 8.1 µg/L, SELENOP; 3.3 ± 1.3 vs. 2.1 ± 0.9 mg/L), recovering with time in survivors while remaining low or even declining in non-survivors. We conclude that Se status analysis in COVID patients provides diagnostic information. However, causality remains unknown due to the observational nature of this study. Nevertheless, the findings strengthen the notion of a relevant role of Se for COVID convalescence and support the discussion on adjuvant Se supplementation in severely diseased and Se-deficient patients.


Subject(s)
Betacoronavirus , Coronavirus Infections/mortality , Pneumonia, Viral/mortality , Selenium/deficiency , Adult , Aged , Aged, 80 and over , Biomarkers/blood , COVID-19 , Coronavirus Infections/epidemiology , Cross-Sectional Studies , Female , Germany/epidemiology , Glutathione Peroxidase/blood , Humans , Male , Middle Aged , Nutritional Status , Pandemics , Pneumonia, Viral/epidemiology , Prognosis , SARS-CoV-2 , Selenium/blood , Selenoprotein P/blood
17.
Nutrients ; 12(6)2020 Jun 25.
Article in English | MEDLINE | ID: mdl-32630589

ABSTRACT

Circulating selenoprotein P (SELENOP) constitutes an established biomarker of Se status. SELENOP concentrations are reduced in inflammation and severe disease. Recently, elevated SELENOP levels have been suggested as diagnostic marker and therapeutic target in pulmonary arterial hypertension (PAH). We decided to re-evaluate this hypothesis. A group of healthy controls (n = 30) was compared with patients suffering from systemic sclerosis (SSc, n = 66), one third with SSc-related PAH. Serum was analysed for trace elements and protein biomarkers, namely SELENOP, glutathione peroxidase 3 (GPx3) and ceruloplasmin (CP). Compared to controls, patients with SSc-related PAH displayed reduced serum Se (91 ± 2 vs. 68 ± 2 µg/L) and SELENOP concentrations (3.7 ± 0.8 vs. 2.7 ± 0.9 mg/L), along with lower GPx3 activity (278 ± 40 vs. 231 ± 54 U/L). All three biomarkers of Se status were particularly low in patients with skin involvement. Serum Cu was not different between the groups, but patients with SSc-related PAH showed elevated ratios of Cu/Se and CP/SELENOP as compared to controls. Our data indicate that patients with SSc-related PAH are characterized by reduced Se status in combination with elevated CP, in line with other inflammatory diseases. Further analyses are needed to verify the diagnostic value of these TE-related biomarkers in PAH.


Subject(s)
Biomarkers/blood , Copper/blood , Pulmonary Arterial Hypertension/blood , Scleroderma, Systemic/blood , Selenium/blood , Adult , Ceruloplasmin/analysis , Cross-Sectional Studies , Female , Glutathione Peroxidase/blood , Humans , Male , Middle Aged , Scleroderma, Systemic/complications , Selenoprotein P/blood
18.
Biomed Pharmacother ; 128: 110265, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32425327

ABSTRACT

OBJECTIVE: This study aimed to determine the optimal extraction process and examine whether the combination of Flos Sophorae Immaturus (FSI) and Yupingfeng san (YPS) has a synergistic effect on free radical scavenging capacity. DESIGN AND METHODS: The time of immersion and extraction and the ratios (material/solvent) of the combination of YPS and FSI were optimized on the basis of polysaccharide and flavonoid yields via orthogonal design. The optimal result was used in the 1,1-diphenyl-1-picrylhydrazyl (DPPH) assay and animal experiments to test the antioxidant activity, which is reflected by superoxide dismutase, malondialdehyde, glutathione peroxidase, and total antioxidant capacity serum levels. The optimal extraction process was determined using various ingredients to obtain complex extracts with high active ingredient content and antioxidant activity. DPPH assay results showed that the optimized ingredients have antioxidant effects, and the combination had better antioxidation function than YPS in vitro. The combination also showed synergistic antioxidant activity compared with YPS in vivo. CONCLUSIONS: The combination of YPS and FSI had a synergistic antioxidant effect in vitro. The optimized extracts had antioxidant effects in vivo. These results indicated that YPS could be used with FSI to improve its antioxidant capacity in the body on the basis of free radical scavenging capacity.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Free Radical Scavengers/pharmacology , Administration, Oral , Animals , Biomarkers/blood , Biphenyl Compounds/chemistry , Drug Synergism , Drugs, Chinese Herbal/administration & dosage , Free Radical Scavengers/administration & dosage , Glutathione Peroxidase/blood , Male , Malondialdehyde/blood , Mice , Picrates/chemistry , Superoxide Dismutase/blood
19.
J Therm Biol ; 89: 102544, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32364987

ABSTRACT

In order to investigate the effects of dietary ginger extract (GE) enriched in gingerols on broilers under heat stress (HS) from 21 to 42 days of age, a total of 144 Ross 308 male broilers were randomly allocated to three groups with six replicates of eight broilers per replicate. Broilers in the control group were raised at 22 °C and fed a basal diet, and broilers in the other two groups were raised under cyclic HS (34 °C from 9:00 to 17:00 and at 22 °C for the rest of the time) and fed the basal diet with or without 1000 mg/kg GE. Supplementation of GE improved (P < 0.05) final body weight, average daily gain and feed conversion ratio of broilers under HS, and tended (P < 0.1) to increase breast muscle yield. The alterations of serum total protein, albumin, total cholesterol levels and aspartate aminotransferase activity under HS were reversed (P < 0.05) by GE, which also decreased (P < 0.05) serum triglyceride level and alanine aminotransferase activity. The decreased redness (a* value) and increased drip loss of breast muscle induced by HS were restored (P < 0.05) by GE. Moreover, GE supplementation increased (P < 0.05) total antioxidant capacity and decreased (P < 0.05) malondialdehyde content in liver and breast muscle, and increased (P < 0.05) glutathione peroxidase activity in serum and breast muscle. In conclusion, dietary GE supplementation restored growth performance, serum metabolites and meat quality of broilers under HS possibly by improving antioxidant activity.


Subject(s)
Antioxidants/pharmacology , Body Size/drug effects , Catechols/pharmacology , Chickens/physiology , Fatty Alcohols/pharmacology , Heat-Shock Response/drug effects , Plant Extracts/pharmacology , Animals , Blood Proteins/analysis , Chickens/blood , Chickens/growth & development , Cholesterol/blood , Zingiber officinale/chemistry , Glutathione Peroxidase/blood , Glutathione Peroxidase/metabolism , Liver/drug effects , Liver/metabolism , Malondialdehyde/blood , Malondialdehyde/metabolism , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Poultry Products/standards , Triglycerides/blood
20.
J Dairy Res ; 87(2): 184-190, 2020 May.
Article in English | MEDLINE | ID: mdl-32295653

ABSTRACT

The hypothesis of the study was that feeding a relatively low amount of Se biofortified alfalfa hay during the dry period and early lactation would improve selenium status and glutathione peroxidase activity in dairy cows and their calves. Ten Jersey and 8 Holstein primiparous dairy cows were supplemented with Se biofortified (TRT; n = 9) or non-biofortified (CTR; n = 9) alfalfa hay at a rate of 1 kg/100 kg of BW mixed with the TMR from 40 d prior parturition to 2 weeks post-partum. Se concentration in whole blood, liver, milk, and colostrum, the transfer of Se to calves, and the glutathione peroxidase (GPx) activity were assessed. TRT had 2-fold larger (P < 0.05) Se in blood v. CTR that resulted in larger Se in liver and colostrum but not milk and larger GPx activity in plasma and erythrocytes but not in milk. Compared to CTR, calves from TRT had larger Se in blood but only a numerical (P = 0.09) larger GPx activity in plasma. A positive correlation was detected between Se in the blood and GPx activity in erythrocytes and plasma in cows. Our results demonstrated that feeding pregnant primiparous dairy cows with a relatively low amount of Se-biofortified alfalfa hay is an effective way to increase Se in the blood and liver, leading to greater antioxidant activity via GPx. The same treatment was effective in improving Se concentration in calves but had a modest effect on their GPx activity. Feeding Se biofortified hay increased Se concentration in colostrum but not in milk.


Subject(s)
Animals, Newborn/metabolism , Cattle/physiology , Glutathione Peroxidase/metabolism , Medicago sativa/chemistry , Postpartum Period/physiology , Selenium/administration & dosage , Animal Feed/analysis , Animals , Colostrum/chemistry , Colostrum/enzymology , Erythrocytes/enzymology , Female , Food, Fortified , Glutathione Peroxidase/blood , Liver/chemistry , Milk/chemistry , Milk/enzymology , Nutritional Status , Pregnancy , Selenium/analysis , Selenium/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL